1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Biomanufacturing Capacity Strategies: Developing a Flexible, Scalable and lean Biomanufacturing system - Overview

The newly published Insight Pharma Reports, Biomanufacturing Capacity Strategies: Developing a Flexible, Scalable, and Lean Biomanufacturing System Report, focus on the need for a more reactive and dynamic biomanufacturing approach than is the current industry standard.

Biomanufacturing is common practice in the life sciences industry and has been continually developed and improved for the last two decades. However, as blockbuster drugs reach the end of their patents, treatment is evolving to become more patient-centric and personalized. The mapping of the human genome has allowed for sophisticated and effective new genetic markers and diagnostic methods to be developed, meaning that personalized medicine is becoming a reality. This has a direct impact on manufacturing, with long-term expected production paradigm shifts in the shape of near-patient manufacturing. Moreover, the rise in incidence of viral pandemics has driven a need for quick set-up, disposable, transportable biomanufacturing. This was a contributing factor to Tamiflu being first to market and will very likely be key in the race to stop the Ebola pandemic.

In addition to covering background information on biomanufacturing and capacity approaches, this report will highlight several technologies, methodologies, and business strategies that can be implemented to improve the capacity and flexibility of biomanufacturing.

Included in this Report:

Detailed the history of biomanufacturing development and the direction for the coming decade
Overview of single-use biomanufacturing techniques and trends, outlining the importance of reactive biomanufacturing
Insight into the Ebola vaccine clinical development, as well as the validation process.
Specific capacity-enhancing approaches ranging from technology solutions to business strategy
Examine the overarching industry pressures that are driving capacity needs, the subsequent regulatory compliance, and where the biggest efficiency and productivity savings can be realized.
Explore the scale-up of biomanufacturing processes to serve commercial scale production, which is currently a major limiting factor in the maturity of this field, and how commercialization of certain therapeutics and regenerative medicines is severely limited by the lack of progression here.
Ventures into the realm of lean thinking and continuous manufacturing methodologies and their application in the field of biomanufacturing with a secondary look at the potential of combining modular facilities with disposable biomanufacturing systems and the technical requirements and advances.
Details a considerable amount with regard to technology transfer and the specific issues relating to biomanufacturing, and outlines some solutions and new approaches to knowledge transfer
Takes a wider view of the context, importance, and impact of biomanufacturing and its capacity to provide a solution to several biotechnology industry challenges.
Provides insight into the field of personalized medicine, cell and gene therapies, and commercial-scale manufacturing vs. near-patient production and the predicted paradigm shift.

Interviews with:

Tony Hitchcock, Technical Director, Cobra Biologics
Jerold Martin, Sr. V.P. Global Scientific Affairs, Biopharmaceuticals, Pall Corporation
Arnaud Schmutz, General Manager, Sourcin
Nigel Smart, Managing Partner, Smart Consulting Group
Keith Thompson, CEO, Cell Therapy Catapult

Results Biomanufacturing Capacity Strategies Survey

Table Of Contents

Biomanufacturing Capacity Strategies: Developing a Flexible, Scalable and lean Biomanufacturing system - Overview
Executive Summary
Introduction and Background Information

Focus of the Report

The History of Biomanufacturing

Single-use biomanufacturing
The advent of single-use biomanufacturing, history, and impact
Current state of market and implementation
Advantages of single-use technologies:
Regulatory Challenges
Obsolete safety testing methods
The importance of flexible and reactive biomanufacturing
Strong business case…but what of implementation and reality?

Biomanufacturing Capacity Strategies, Opportunities, and Challenges

Strategies to increase capacity and flexibility

External Factors Affecting Capacity, Challenges, and Opportunities

Operational Excellence and Cost Reduction

The Future of the Biomanufacturing Industry and Profession

Biomanufacturing Capacity Innovation as a Solution to Biotechnology Industry Challenges

How Market Trends and Predictions Will Affect the Production Paradigm
Industry Interview Transcripts
Tony Hitchcock
Jerold Martin
Arnaud Schmutz
Nigel Smart
Keith Thompson

Survey Results

Results from Insight Pharma Reports Survey on Biomanufacturing Capacity Strategies


About Cambridge Healthtech Institute

Table 2.1 Regulations in EU Member States regarding hES1 cell research
Table 5.1: Factors Influencing Capacity and Flexibility Needs

Figure 4.1: Levels of Increase in Biomanufacturing by 2020
Figure 4.2: Manufacturing Capacity Strategies Overview
Figure 4.3: Modular Facilities Implementation
Figure 4.4: Single-Use Technology Implementation
Figure 4.5: Outsourcing Implementation
Figure 4.6: Offshoring Implementation
Figure 5.1: Factors Driving Biomanufacturing Capacity Needs
Figure 5.2: Biomanufacturing challenges 2015-2020
Figure 8.1: BioPharma Strategy - New Paradigm

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Biobanking: Technologies and Global Markets

Biobanking: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Analyze the role biobanks play in the development of new drugs for specific disease treatments. - Learn about the prevailing market size for certain biobank services available ...

Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets

Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets

  • $ 6650
  • Industry report
  • January 2017
  • by BCC Research

Use this report to: - Assess current market dynamics and estimate future demand for sample preparation in genomics, proteomics and epigenomics. - Gain insight into existing products as well as new developments ...

2016 Global Survey on Clinical Next-Generation Sequencing

2016 Global Survey on Clinical Next-Generation Sequencing

  • $ 6000
  • Industry report
  • January 2017
  • by Frost & Sullivan

Respondents Show Vivid Interest in Developing Clinical NGS-based Tests for Infectious Disease Testing Applications The primary goal of this research is to analyze the current and future adoption plans ...

Download Unlimited Documents from Trusted Public Sources

Genetic Industry in China

  • March 2017
    25 pages
  • Genetic  

    Genetic Disorde...  

  • China  

View report >

Genetic Industry in China

  • March 2017
    17 pages
  • Genetic  

  • China  

View report >

Genetic Industry in Africa

  • March 2017
    12 pages
  • Genetic  

  • Africa  

    United States  

View report >

Genomics Statistics

8 days ago


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.